Tillotts Pharma competitive analysis

Loading summary...

Explore patent oppositions filed by Tillotts Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture ThereofSOFARFeb 28, 2019
Mesalazine Tablet Having Improved DissolutionDISPHARNov 21, 2018
Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 5, 2018

Explore Tillotts Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 23, 2022Preparation Of Solid Dosage Forms Comprising Antibodies By Solution/Suspension Layering1

Latest publications and patents of Tillotts Pharma New

Explore the latest publications and patents granted to Tillotts Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Oct 17, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Tillotts Pharma

Nov 23, 2022Preparation Of Solid Dosage Forms Comprising Antibodies By Solution/Suspension LayeringOpposition Rejected

Latest PTAB cases involving Tillotts Pharma

Discover the latest PTAB cases involving Tillotts Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Tillotts Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TILLOTTS PHARMA31 - -
CHUGAI SEIYAKU KABUSHIKI KAISHA377 - 1
DISPHAR - 1 - -
HEIROTH1 - - -